E
Epitomee Medical Ltd
TASE:EPIT
Epitomee Medical Ltd
TASE:EPIT
Price:
842.8
ILS
-3.82%
Market Closed
Market Cap:
₪248.7m
Balance Sheet
Balance Sheet Decomposition
Epitomee Medical Ltd
Epitomee Medical Ltd
Balance Sheet Decomposition is not available for
Epitomee Medical Ltd
Epitomee Medical Ltd
Balance Sheet
Epitomee Medical Ltd
Epitomee Medical Ltd
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
7
|
5
|
64
|
36
|
16
|
17
|
|
| Cash Equivalents |
7
|
5
|
64
|
36
|
16
|
17
|
|
| Short-Term Investments |
0
|
16
|
0
|
10
|
19
|
6
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
7
|
21
|
65
|
47
|
35
|
22
|
|
| PP&E Net |
1
|
1
|
1
|
8
|
5
|
17
|
|
| PP&E Gross |
1
|
1
|
1
|
8
|
5
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
8
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
21
+177%
|
66
+210%
|
55
-16%
|
40
-27%
|
40
0%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
1
|
1
|
2
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
7
|
0
|
4
|
4
|
4
|
|
| Other Liabilities |
0
|
10
|
10
|
10
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
17
+2 085%
|
13
-27%
|
16
+24%
|
5
-65%
|
6
+15%
|
|
| Equity | |||||||
| Common Stock |
30
|
30
|
90
|
90
|
90
|
90
|
|
| Retained Earnings |
24
|
27
|
38
|
54
|
60
|
61
|
|
| Other Equity |
1
|
1
|
2
|
3
|
4
|
5
|
|
| Total Equity |
7
N/A
|
4
-42%
|
53
+1 240%
|
39
-26%
|
35
-12%
|
34
-2%
|
|
| Total Liabilities & Equity |
8
N/A
|
21
+177%
|
66
+210%
|
55
-16%
|
40
-27%
|
40
0%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
29
|
29
|
29
|
30
|
30
|
30
|
|
Switch to:
Switch to:
See Also
Discover More
